ClinicalTrials.govpublic full text
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
recurrent glioblastoma, recurrent malignant glioma, recurrent who grade ii glioma, recurrent who grade iii glioma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 253083
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.